RANDOMIZED STUDY OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) VERSUS TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLUAR CARCINOMA
Primary Sponsor
Trial Contact
qa@trog.com.au
Related Post
5 December, 2024
Extended follow-up of TROG 99.03 lymphoma trial published
5 December 2024: Study shows huge improvement in progression-free
28 November, 2024
Meet TROG President: A/Prof Puma Sandaresan
28 November 2024: In this Q&A, TROG President A/Prof
